Released Oct 28, 2019, after the close
10-Q filed Oct 28, 2019, 28 days after period end · 0001564590-19-038146
Q3 2019 · 10-Q
Revenue$113.50M$113.50M +1.6% vs Q3 2018−2.0% vs Q2 2019
Net Income-$40.50M-$40.50M N/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$2.14-$2.14 N/M vs Q3 2018N/M vs Q2 2019
Gross Profit$88,603,000+1.0%
Operating Income-$18,882,000N/M
Operating Cash Flowderived$11,746,000−25.6%
Free Cash Flowderived$7,604,000−36.6%
Margins · derived
Gross margin78.1%−0.4 pt vs Q3 2018
Operating margin-16.6%−20.1 pt vs Q3 2018
Net margin-35.7%−34.6 pt vs Q3 2018
What the release said
The release
Same quarter
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $113.50M | $111.71M | $105.25M | $98.50M |
| Net Income | -$40.50M | -$1.21M | $3.46M | $9.90M |
| EPS Diluted | -$2.14 | -$0.07 | $0.19 | $0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR